XML 14 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2017
Dec. 31, 2016
ASSETS    
Cash and cash equivalents $ 312,727 $ 454,030
Grant funds receivable 59,758 28,074
Prepaid expenses and other current assets 75,589 62,275
Total current assets 448,074 544,379
Property and equipment, net 31,151 54,828
Deposits 11,010 11,010
Total assets 490,235 610,217
Current liabilities:    
Accounts payable 77,581 75,607
Accrued expenses (Note 4) 733,711 294,240
Total current liabilities 811,292 369,847
Commitments (Note 6)
Stockholders’ equity (deficiency):    
Common stock, $.001 par value: Authorized shares – 600,000,000 and 300,000,000 at September 30, 2017 and December 31, 2016, respectively Issued and outstanding shares – 70,913,900 and 55,235,233 at December 31, 2017 and 2016, respectively 106,737 55,235
Additional paid-in capital 35,589,911 34,914,963
Accumulated deficit (37,916,790) (35,746,628)
Total stockholders’ equity (deficiency) (321,057) 240,370
Total liabilities and stockholders’ equity 490,235 610,217
Series B Convertible Preferred Stock [Member]    
Stockholders’ equity (deficiency):    
Convertible Preferred Stock 76,095 76,095
Series C Convertible Preferred Stock [Member]    
Stockholders’ equity (deficiency):    
Convertible Preferred Stock 842,990 940,705
Series D Convertible Preferred Stock [Member]    
Stockholders’ equity (deficiency):    
Convertible Preferred Stock $ 980,000